Literature DB >> 19001438

Involvement of c-FLIP and survivin down-regulation in flexible heteroarotinoid-induced apoptosis and enhancement of TRAIL-initiated apoptosis in lung cancer cells.

Yidan Lin1, Xiangguo Liu, Ping Yue, Doris M Benbrook, K Darrell Berlin, Fadlo R Khuri, Shi-Yong Sun.   

Abstract

The flexible heteroarotinoid, SHetA2, is a novel compound with apoptosis-inducing and anticancer activities in vitro and in vivo. Our previous research showed that up-regulation of death receptor 5 plays a critical role in the mechanism of SHetA2-induced apoptosis in human lung cancer cells. The hypothesis of this study was that the mechanism of SHetA2-induced apoptosis requires modulation of additional proteins critical for regulation of apoptosis, including cellular FLICE-inhibitory protein (c-FLIP), survivin, X-linked inhibitor of apoptosis, Bcl-2, Bcl-X(L), Bax, and Bim. Western blot analysis showed that c-FLIP and survivin were substantially reduced in all of the tested cell lines exposed to SHetA2 compared with other proteins that were reduced only in a subset of the cell lines tested. Strikingly, overexpression of c-FLIP, but not survivin, protected cells from SHetA2-induced apoptosis and enhancement of TRAIL-initiated apoptosis, although knockdown of endogenous survivin did slightly sensitize cells to SHetA2-induced apoptosis. Consistent with these results, small interfering RNA-mediated reduction of c-FLIP was more effective than survivin down-regulation in triggering apoptosis in these cell lines. SHetA2 increased ubiquitination of c-FLIP and the consequent degradation was abrogated by the proteasome inhibitor MG132. Although SHetA2 treatment led to increased c-Jun phosphorylation, the JNK inhibitor SP600125 did not prevent c-FLIP down-regulation by SHetA2. Thus, it appears that SHetA2 down-regulates c-FLIP levels by facilitating its ubiquitin/proteasome-mediated degradation independent of JNK activation. Collectively, the present study indicates that, in addition to death receptor 5 up-regulation, c-FLIP down-regulation is another important component of flexible heteroarotinoid (SHetA2)-induced apoptosis as well as enhancement of TRAIL-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001438     DOI: 10.1158/1535-7163.MCT-08-0648

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  26 in total

Review 1.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Authors:  Adi F Gazdar; Boning Gao; John D Minna
Journal:  Lung Cancer       Date:  2010-01-15       Impact factor: 5.705

2.  Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis.

Authors:  B Wang; M Xie; R Li; T K Owonikoko; S S Ramalingam; F R Khuri; W J Curran; Y Wang; X Deng
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

3.  Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cells.

Authors:  Yan Liu; Shi-Yong Sun; Taofeek K Owonikoko; Gabriel L Sica; Walter J Curran; Fadlo R Khuri; Xingming Deng
Journal:  Mol Cancer Ther       Date:  2011-11-04       Impact factor: 6.261

4.  The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition.

Authors:  Bo Li; Hui Ren; Ping Yue; Mingwei Chen; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-16

5.  The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.

Authors:  Liqun Zhao; Ping Yue; Sagar Lonial; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cancer Ther       Date:  2011-09-13       Impact factor: 6.261

6.  Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells.

Authors:  Liang-Cheng Li; Shankar Jayaram; Lakshmy Ganesh; Lixia Qian; Jacob Rotmensch; Ajay V Maker; Bellur S Prabhakar
Journal:  Am J Obstet Gynecol       Date:  2011-05-27       Impact factor: 8.661

7.  Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity.

Authors:  Doris Mangiaracina Benbrook; Suresh Guruswamy; Yuhong Wang; Zhongjie Sun; Altaf Mohammed; Yuting Zhang; Qian Li; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2013-07-12

8.  c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589.

Authors:  John Kauh; Songqing Fan; Mingjing Xia; Ping Yue; Lily Yang; Fadlo R Khuri; Shi-Yong Sun
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

9.  Development of flexible-heteroarotinoids for kidney cancer.

Authors:  Tongzu Liu; Chioniso Patience Masamha; Shylet Chengedza; K Darrell Berlin; Stan Lightfoot; Feng He; Doris Mangiaracina Benbrook
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

10.  A novel derivative of tetrandrine (H1) induces endoplasmic reticulum stress-mediated apoptosis and prosurvival autophagy in human non-small cell lung cancer cells.

Authors:  Yidan Lin; Yu Wang; Xianfang Liu; Jiamei Yan; Ling Su; Xiangguo Liu
Journal:  Tumour Biol       Date:  2016-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.